Abstract
Hepatitis delta virus (HDV) infection causes fulminant hepatitis and liver cirrhosis. To elucidate the molecular mechanism of HDV pathogenesis, we examined the effects of HDV viral proteins, the small hepatitis delta antigen (SHDAg) and the large hepatitis delta antigen (LHDAg), on NF-κB signaling pathway. In this study, we demonstrated that TNF-α-induced NF-κB transcriptional activation was increased by LHDAg but not by SHDAg in both HEK293 and Huh7 cells. Furthermore, LHDAg promoted TRAF2-induced NF-κB activation. Using coimmunoprecipitation assays, we demonstrated that both SHDAg and LHDAg interacted with TRAF2 protein. We showed that isoprenylation of LHDAg was not required for the increase of NF-κB activity. We further showed that only LHDAg but not SHDAg increased the TNF-α-mediated nuclear translocation of p65. This was accomplished by activation of IκBα degradation by LHDAg. Finally, we demonstrated that LHDAg augmented the COX-2 expression level in Huh7 cells. These data suggest that LHDAg modulates NF-κB signaling pathway and may contribute to HDV pathogenesis.
Similar content being viewed by others
References
Aggarwal, B.B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203–208.
Baeuerle, P.A., and Baltimore, D. (1996). NF-kappa B: ten years after. Cell 87, 13–20.
Baldwin, A.S.Jr. (1996). The NF-kappa B and IkappaB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649–683.
Barnes, P.J., and Karin, M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066–1071.
Casey, J.L., and Gerin, J.L. (1995). Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J. Virol. 69, 7593–7600.
Chang, F.L., Chen, P.J., Tu, S.J., Wang, C.J., and Chen, D.S. (1991). The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc. Natl. Acad. Sci. USA 88, 8490–8494.
Chao, M., Hsieh, S.Y., and Taylor, J. (1990). Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J. Virol. 64, 5066–5069.
Chen, P.J., Chang, F.L., Wang, C.J., Lin, C.J., Sung, S.Y., and Chen, D.S. (1992). Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the amino-terminal leucine zipper. J. Virol. 66, 2853–2859.
Choi, S.H., Park, K.J., Ahn, B.Y., Jung, G., Lai, M.M.C., and Hwang, S.B. (2006). Hepatitis C virus ninstructural 5B protein regulates tumor necrosis factor alpha signaling through effects on cellular I-κB kinase. Mol. Cell. Biol. 26, 3048–3059.
Chung, Y.M., Park, K.J., Choi, S.Y., Hwang, S.B., and Lee, S.Y. (2001). Hepatitis C virus core protein potentiates TNF-α-induced NF-κB activation through TRAF2-IKKβ-dependent pathway. Biochem. Biophys. Res. Commun. 284, 15–19.
DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin, M. (1997). A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388, 548–554.
Farci, P. (2003). Delta hepatitis: an update. J. Hepatol. 39, S212–S219.
Fernholz, D., Galle, P.R., Stemler, M., Runetto, M.B., Bonino, F., and Will, H. (1993). Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 194, 137–148.
Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109, S81–S96.
Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225–260.
Glenn, J.S., Watson, J.A., Havel, C.M., and White, J.M. (1992). Identification of a prenylation site in delta virus large antigen. Science 256, 1331–1333.
Hideo, Y., Kato, N., Shiratori, Y., Otsuka, M., Maeda, S., Kato, J., and Omata, M. (2001). Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J. Biol. Chem. 276, 16399–16405.
Hwang, S.B., and Lai, M.M.C. (1993). Isoprenylation mediates direct proteinprotein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J. Virol. 67, 7659–7662.
Hwang, S.B., Lee, C.Z., and Lai, M.M.C. (1992). Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms. Virology 190, 413–422.
Hwang, S.B., Park, K.J., and Kim, Y.S. (1998). Overexpression of hepatitis delta antigen protects insect cells from baculovirus-induced cytolysis. Biochem. Biophys. Res. Commun. 244, 652–658.
Karin, M., and Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18, 621–663.
Kos, A., Dijkema, R., Arnberg, A.C., Van der Meide, P.H., and Schellekens, H. (1986). The hepatitis delta (δ) virus possesses a circular RNA. Nature 323, 558–560.
Kuo, M.Y., Chao, M., and Taylor, J. (1989). Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J. Virol. 63, 1945–1950.
Lai, M.M.C. (1995). The molecular biology of hepatitis delta virus. Annu. Rev. Biochem. 64, 259–286.
Lee, C.Z., Chen, P.J., Lai, M.M., and Chen, D.S. (1994). Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly. Virology 199, 169–175.
Lee, S.Y., Lee, S.Y., Kandala, G., Liou, M.-L., Liou, H.C., and Choi, Y. (1997). CD30/TNF receptor-associated factor interaction: NFkappaB activation and binding specificity. Proc. Natl. Acad. Sci. USA 93, 9699–9703.
Luo, G.X., Chao, M., Hsieh, S.Y., Sureau, C., Nishikura, K., and Taylor, J. (1990). A specific base transition occurs on replicating hepatitis delta virus RNA. J. Virol. 64, 1021–1027.
Makino, S., Chang, M.F., Shieh, C.K., Kamahora, T., Vannier, D.M., Govindarajan, S., and Lai, M.M.C. (1987). Molecular cloning and sequencing of a human hepatitis delta (δ) virus RNA. Nature 329, 343–346.
Mercurio, F., Zhu, H., Murray, B.W., Shevchenko, A., Bennett, B.L., Li, J., Young, D.B., Barbosa, M., Mann, M., Manning, A., et al. (1997). IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278, 860–866.
Mizuno, T., Kaibuchi, K., Yamamoto, T., Kawamura, M., Sakoda, T., Fujioka, H., Matsuura, Y., and Takai, Y. (1991). A stimulatory GDP/GTP exchange protein for smg p21 is active on the posttranslationally processed form of c-Ki-ras p21 and rhoA p21. Proc. Natl. Acad. Sci. USA 88, 6442–6446.
Niro, G.A., Rosina, F., and Rizzetto, M. (2005). Treatment of hepatitis D. J. Viral. Hepat. 12, 2–9.
Park, K.J., Choi, S.H., Koh, M.S., Kim, D.J., Yie, S.W., Lee, S.Y., and Hwang, S.B. (2001). Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2. Virus Res. 74, 89–98.
Park, K.J., Choi, S.H., Lee, S.Y., Hwang, S.B., and Lai, M.M.C. (2002). Nonstructural 5A protein of hepatitis C virus modulates tumor necrosis factor α-stimulated nuclear factor κB activation. J. Biol. Chem. 277, 13122–13128.
Park, C.Y., Jun H.J., Wakita T., Cheong J.H., and Hwang, S.B. (2009). Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J. Biol. Chem. 284, 9237–9246.
Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z., and Rothe, M. (1997). Identification and characterization of an IkappaB kinase. Cell 90, 373–383.
Rizzetto, M., Hoyer, B., Canese, M.G., Shih, J.W., Purcell, R.H., and Gerin, J.L. (1980). Delta agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc. Natl. Acad. Sci. USA 77, 6124–6128.
Rothwarf, D.M., Zandi, E., Natoli, G., and Karin, M. (1998). IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 395, 297–300.
Ryu, W.S., Bayer, M., and Taylor, J.M. (1992). Assembly of hepatitis delta virus particles. J. Virol. 66, 2310–2315.
Shrivastava, A., Manna, S.K., Ray, R., and Aggarwal, B.B. (1998). Etopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J. Virol. 72, 9722–9728.
Silverman, N., and Maniatis, T. (2001). NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15, 2321–2342.
Thanos, D., and Maniatis, T. (1995). NF-kappaB: a lesson in family values. Cell 80, 529–532.
Wang, K.S., Choo, Q.L., Weiner, A.J., Ou, J.H., Najarian, R.C., Thayer, R.M., Mullenbach, G.T., Denniston, K.J., Gerin, J.L., and Houghton, M. (1986). Structure, sequence, and expression of the hepatitis delta (delta) viral genome. Nature 323, 508–514.
Weil, R., Sirma, H., Giannini, C., Kremsdorf, D., Bessia, C., Dargemont, C., Brechot, C., and Israel, A. (1999). Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor IκBα. Mol. Cell. Biol. 19, 6345–6354.
Whiteside, S.T., and Israel, A. (1997). IkappaB proteins: structure, function and regulation. Semin. Cancer Biol. 8, 75–82.
Woronicz, J.D., Gao, X., Cao, Z., Rothe, M., and Goeddel, D.V. (1997). IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278, 866–869.
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S.T., Weil, R., Agou, F., Kirk, H.E., Kay, R.J., and Israel, A. (1998). Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93, 1231–1240.
Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., and Karin, M. (1997). The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91, 243–252.
Zandi, E., Chen, Y., and Karin, M. (1998). Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB bound substrate. Science 281, 1360–1363.
Zhu, N., Khoshnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C., and Lai, M.M.C. (1998). Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72, 3691–3697.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
About this article
Cite this article
Park, CY., Oh, SH., Kang, S.M. et al. Hepatitis delta virus large antigen sensitizes to TNF-α-induced NF-κB signaling. Mol Cells 28, 49–55 (2009). https://doi.org/10.1007/s10059-009-0100-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-009-0100-5